GlassScriptPhysician profile
Rene Boothby
NPI 1215023023
$2,660.99
in general payments reported to CMS, 2019-2025
26 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $317 · 2021: $182 · 2022: $518 · 2023: $445 · 2024: $272 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $534.78 | 2019-2024 | Dupixent |
| Optinose US, INC. | $504.38 | 2019-2025 | |
| Glaxosmithkline, LLC. | $212.31 | 2019-2025 | Nucala |
| Genzyme Corporation | $184.59 | 2019-2025 | |
| Aerin Medical INC. | $164.64 | 2020-2024 | |
| Kaleo, INC. | $154.63 | 2019-2022 | |
| Stryker Corporation | $141.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $121.13 | 2019-2022 | |
| Intersect Ent, INC. | $116.57 | 2019 | |
| Medtronic USA, INC. | $73.24 | 2020 | |
| Alk-Abello, INC | $64.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $43.75 | 2021 | |
| Acclarent, INC | $42.32 | 2019-2020 | |
| Phadia US INC. | $41.73 | 2023-2024 | Immunocap |
| C2dx, INC | $34.32 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $32.52 | 2023 | Inspire |
| Itamar Medical INC | $31.71 | 2025 | Watchpatone |
| Lucid Diagnostics INC. | $28.70 | 2023 | |
| Sanofi-Aventis U.S. LLC | $22.03 | 2020 | |
| Integra Lifesciences Corporation | $19.10 | 2023 | Codman Isocool Aht, Integra Duo, Microfrance |
| Hikma Pharmaceuticals USA | $17.97 | 2025 | Ryaltris |
| Merck Sharp & Dohme LLC | $16.20 | 2023 | |
| Acera Surgical, INC. | $15.61 | 2023 | Restrata Wound Matrix |
| Amgen INC. | $15.35 | 2025 | |
| Aimmune Therapeutics, INC. | $15.25 | 2022 | |
| Glenmark Therapeutics INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Boothby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.